Navigating Accredited Stem Cell Therapy Clinics
The regenerative medicine landscape includes hundreds of clinics worldwide offering stem cell therapies, but only a subset hold recognized accreditations that validate their safety protocols, lab standards, and clinical processes. This dataset focuses exclusively on facilities with verifiable credentials from bodies such as FACT (Foundation for the Accreditation of Cellular Therapy), AABB, JCI (Joint Commission International), or national GMP (Good Manufacturing Practice) certifications.
Why Accreditation Matters
Stem cell therapy is a rapidly growing field with significant variability in quality. Accreditation serves as a filter separating evidence-based programs from clinics making unverified claims. FACT alone accredits over 319 organizations in the U.S., each meeting rigorous standards for cell collection, processing, storage, and administration. Internationally, GMP certification and JCI accreditation provide comparable quality benchmarks.
Key Accreditation Bodies
- FACT
- The gold standard for cellular therapy programs. Covers hematopoietic cell transplant, immune effector cell therapy, and more. Requires regular re-inspection.
- AABB
- Accredits cellular therapy facilities including cord blood banks, HPC processing labs, and somatic cell therapy programs. Biennial assessment cycle.
- JCI
- International hospital accreditation recognizing overall patient safety and care quality. Common among medical tourism destinations in Turkey, South Korea, and the Middle East.
- GMP / EU GMP
- Manufacturing-level certification for cell processing labs. Required in the EU for advanced therapy medicinal products (ATMPs). Increasingly adopted in Asia.
Geographic Distribution
The highest concentration of accredited facilities is in North America (predominantly FACT and AABB accredited), followed by Western Europe (EU GMP and JACIE standards), and growing clusters in South Korea, Japan, Turkey, and the Middle East. Medical tourism hubs like the Cayman Islands and Thailand have also developed accredited programs targeting international patients.